The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
"Imagine they took part in the placing to stop the company going under and losing their original investment. Risky but paid off."
So why didn't the other IIs, such as Octopus and WT Lamb, support the SP by adding after that business update last September? There was no guarantee the SP would recover above the 7p placing.
I don't trust the FUM management whatsoever. CSD was supposed to be a blockbuster but has failed miserably and they paid themselves well over a hundred grand in bonuses despite not sealing the deal they promised and despite having so little money they had to do a fund raise. Pigs in troughs oink oink.
For your sakes I hope the much feared placebo issue doesn't raise its head in Phase 3.
Beware the rampers on here. They all arrive "at the same time" and they all disappear "at the same time". Work that one out!
Also they're ramming £1.40 per share down everyone's necks as a dead cert but at the same time saying it's OK for Lombard to "take profit" when their argument suggests they're forsaking TWO MILLION QUID on their latest offload through being impatient.
Contradiction after contradiction.
Their motive is clearly a pump and dump. Listen to Hawky.
Totally disagree, Thomas. When the directors get paid a massive bonus for apparently nothing when cash preservation is extremely important, you have to ask what on earth is going on.
All last year Barder was beefing this up talking about considerable interest with punching numbers but all that happened was a severe share dilution. You have to ask yourself if the interest really is there and did these "considerably interested" potential partners unearth some serious flaws in their due diligence?
Also no further launches of CSD and even though it's non-core it's been nearly a year now since the 2 year shelf life so again you have to ask yourself if anything's going on here.
If MED is as fantastic as the rampers make out on here it would have been snapped up a long time ago and certainly a prominent player would be stake building at this market cap.
IMO this AIM gravy train is sucking in a barrel load of mugs which will end in tears for FUM shareholders.
Very strong sell!
Looks like a few read my posts as the SP heads south in a sea of red. These AIM companies shouldn't be able to get away with paying bonuses on the back of a fund raise especially when no revenue generating deals have been made.
I would love to know how these "precise" bonuses have been calculated and on what "achievement", especially when they are greater than the national average salary for a FULL YEAR'S WORK!
Another gravy train AIM carry on fleecing the Market. Shame on you!
Very strong sell.
And another thing that makes me laugh, Thomas, is the directors "boasting" they were taking part in the last fund raising:
https://www.londonstockexchange.com/exchange/news/market-news/market-news-detail/FUM/13834780.html
...… but they have taken MORE out of the company with these unexplained bonuses! OUTRAGEOUS! The snakes doth slither through the grass.
Bonuses are a reward for generating revenue/profits - they're effectively a share of what one has earned for the company. So how can it be justified to award a total of £125k bonuses when there has been ZERO revenue for the year? Even if they're grilled at the AGM they'll probably just shrug their shoulders claiming the awards to be "fairly agreed". PMSL.
The only saving grace for this dog is that MED "might" come off but I wouldn't trust this lot as far as I can throw them. Using much needed funds whilst in a loss making situation to line the directors' pockets with FAT bonuses is a disgrace.
I see FUM have now finally published their annual report for 2018 on their website.
Can someone please provide some kind of explanation why Barder and Hildreth got a bonus of £44k each and Ken James £36k, in particular when Barder kept telling shareholders that a deal would be closed and kept talking punchy numbers, when all that happened was a severe share dilution? I also note that Derek Martin had a £55k pay off. A small company conserving cash for the benefit of shareholders, or the usual AIM gravy train?
I suggest the latter. Pigs snouts in troughs. Strong sell.
It wouldn't because the 15% on 1.4 billion sales is rubbish. The sales mentioned are RETAIL prices and the 15% royalties (if true) would be on the WHOLESALE. I cannot see how Boots (foe example) would pay FUM 15% when the partnership would be between the supplier (Pfizer, for example) so the royalties will be far far less than the rampers are ramping on here.
LOL!!!!!!!!!!!!!!!!!!!!!!!!!!! I have never ever ever never known a nomad have any influence on the fortunes of a company. As I say, just like auditors, nomads are a waste of space. Don't believe the lying rampers on here.
Despite approaching so called game changing Phase 3 data, looks like the Market doesn't share the over inflated optimism of some. It begs the question if anyone is actually interested in MED, the same way as the only territory selling "disruptive" technology CSD is a minor county far far away.
Best way to play this is ride the waves, and I should know, I've made a few more grand on the recent spike. Looks weak at the moment so be prepared for a further drop (hence my "sell" recommendation), then wait for the next wave of ramps to make a quick buck. It's easy!